A detailed history of Geode Capital Management, LLC transactions in Catalent, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 4,265,795 shares of CTLT stock, worth $262 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,265,795
Previous 4,310,664 1.04%
Holding current value
$262 Million
Previous $242 Million 6.6%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$56.16 - $60.96 $2.52 Million - $2.74 Million
-44,869 Reduced 1.04%
4,265,795 $258 Million
Q2 2024

Aug 09, 2024

BUY
$53.58 - $57.02 $7.31 Million - $7.78 Million
136,467 Added 3.27%
4,310,664 $242 Million
Q1 2024

May 13, 2024

BUY
$42.56 - $59.82 $5.85 Million - $8.23 Million
137,515 Added 3.41%
4,174,197 $236 Million
Q4 2023

Feb 13, 2024

BUY
$32.18 - $46.57 $2.68 Million - $3.88 Million
83,311 Added 2.11%
4,036,682 $181 Million
Q3 2023

Nov 13, 2023

BUY
$44.2 - $50.2 $3 Million - $3.4 Million
67,761 Added 1.74%
3,953,371 $180 Million
Q2 2023

Aug 11, 2023

BUY
$31.86 - $67.26 $5.28 Million - $11.2 Million
165,814 Added 4.46%
3,885,610 $168 Million
Q1 2023

May 15, 2023

BUY
$45.44 - $74.26 $4.16 Million - $6.8 Million
91,627 Added 2.53%
3,719,796 $244 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $5.03 Million - $9.84 Million
121,525 Added 3.47%
3,628,169 $163 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $5.76 Million - $9 Million
79,559 Added 2.32%
3,506,644 $253 Million
Q2 2022

Aug 12, 2022

BUY
$87.2 - $114.05 $1.88 Million - $2.46 Million
21,534 Added 0.63%
3,427,085 $367 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $27.1 Million - $35.9 Million
287,981 Added 9.24%
3,405,551 $377 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $14.7 Million - $17.1 Million
122,853 Added 4.1%
3,117,570 $398 Million
Q3 2021

Nov 12, 2021

BUY
$109.17 - $142.35 $6.36 Million - $8.29 Million
58,270 Added 1.98%
2,994,717 $397 Million
Q2 2021

Aug 13, 2021

BUY
$100.34 - $115.69 $8,428 - $9,717
84 Added 0.0%
2,936,447 $317 Million
Q1 2021

May 12, 2021

BUY
$101.51 - $125.27 $8.51 Million - $10.5 Million
83,883 Added 2.94%
2,936,363 $308 Million
Q4 2020

Feb 12, 2021

BUY
$85.88 - $105.36 $7.4 Million - $9.08 Million
86,170 Added 3.11%
2,852,480 $296 Million
Q3 2020

Nov 13, 2020

BUY
$72.74 - $92.5 $67 Million - $85.2 Million
920,599 Added 49.88%
2,766,310 $237 Million
Q2 2020

Aug 13, 2020

BUY
$48.02 - $79.04 $4.08 Million - $6.71 Million
84,893 Added 4.82%
1,845,711 $135 Million
Q1 2020

May 14, 2020

BUY
$36.95 - $62.95 $5.41 Million - $9.21 Million
146,302 Added 9.06%
1,760,818 $91.5 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $2.78 Million - $3.35 Million
59,104 Added 3.8%
1,614,516 $90.9 Million
Q3 2019

Nov 12, 2019

BUY
$47.45 - $58.05 $1.28 Million - $1.57 Million
27,027 Added 1.77%
1,555,412 $74.1 Million
Q2 2019

Aug 14, 2019

BUY
$39.26 - $54.21 $1.85 Million - $2.56 Million
47,230 Added 3.19%
1,528,385 $82.9 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $1.74 Million - $2.56 Million
58,295 Added 4.1%
1,481,155 $60.1 Million
Q4 2018

Feb 13, 2019

BUY
$29.95 - $46.34 $3.25 Million - $5.02 Million
108,407 Added 8.25%
1,422,860 $44.4 Million
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $5.58 Million - $6.33 Million
138,988 Added 11.82%
1,314,453 $59.9 Million
Q2 2018

Aug 14, 2018

SELL
$38.72 - $42.52 $833,564 - $915,370
-21,528 Reduced 1.8%
1,175,465 $49.2 Million
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $2.11 Million - $2.54 Million
53,669 Added 4.69%
1,196,993 $49.1 Million
Q4 2017

Feb 13, 2018

BUY
$37.27 - $43.02 $2.41 Million - $2.78 Million
64,532 Added 5.98%
1,143,324 $47 Million
Q3 2017

Nov 14, 2017

BUY
$33.75 - $41.67 $652,320 - $805,397
19,328 Added 1.82%
1,078,792 $43.1 Million
Q2 2017

Aug 14, 2017

BUY
N/A
1,059,464
1,059,464 $37.2 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.1B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.